Clinical Trial: A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647133) titled 'A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease' on June 09.

Brief Summary: This study will evaluate the efficacy and safety of SAL0140 in patients with chronic kidney disease (CKD).

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Chronic Kidney Disease

Intervention: DRUG: SAL0140 Tablets

SAL0140 Tablets

DRUG: SAL0140 Tablets

SAL0140 Tablets

DRUG: SAL0140 placebo

placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.

Published by HT Digital Content Services with permission from Health Dail...